| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 03/27/2008 | US20080076793 Use of an ascomycin for the treatment of blepharitis |
| 03/27/2008 | US20080076787 Crystalline antifungal compounds |
| 03/27/2008 | US20080076768 Pharmaceutical compounds |
| 03/27/2008 | US20080076758 1S,4S)-2-((2-(1H-indazol-4-yl)-4- morpholinothieno[3,2-d]pyrirnidin-6- yl)methyl)-5-methylsulfonyl-2,5- diaza-bicyclo[2.2.1]heptane; 2-(6-fluoropyridin-3-yl)-6-((4- methylsulfonylpiperazin-1-yl)methyl)-4- morpholinothieno[3,2-d]pyrimidine; treats cancer mediated by pik3 kinase; enzyme inhibitors |
| 03/27/2008 | US20080076755 4-(Adamantane-1-carbonylamino)-3-oxo-2-aza-bicyclo[2.2.2]octane; 5-(Adamantane-1-carbonylamino)-10-oxo-9-aza-bicyclo[3.3.2]decane for treating autoimmune diseases, vascular disorders, viral infection or replication, asthma, osteoporosis, tumor growth, rheumatoid arthritis, organ transplant rejection |
| 03/27/2008 | US20080076746 Method of Treating Fish and Crustaceans With a Tellurium Based Immunomodulator |
| 03/27/2008 | US20080076745 Antibacterial amide macrocycles iv |
| 03/27/2008 | US20080076741 can be coadministered with antimicrobial agents for treatment of infections caused by drug resistant bacteria; 2-Amino-N-{4-Amino-1-[-3-phenyl-1-(R)-(quinolin-3-ylcarbomoyl)-propylcarbamoyl]-butyl}succinamic acid; 2,5-Diamino-pentanoic acid [3-phenyl-1-(R)-(4-phenyl-thiazol-2-ylcarbamoyl)-propyl]-amide |
| 03/27/2008 | US20080076740 Phosphonate Analogs Of Hiv Integrase Inhibitor Compounds; antiviral: improved pharmacokinetics; conjugate comprising a compound that inhibits HIV linked to one or more phosphonate groups |
| 03/27/2008 | US20080076738 antiviral: improved pharmacokinetics |
| 03/27/2008 | US20080076726 Methods and compositions for the treatment of asthma and related disorders |
| 03/27/2008 | US20080076725 less hygroscopic |
| 03/27/2008 | US20080076718 oligopeptide or polypeptide amino acid sequences as biodrug antitumor agents, anticarcinogenic agents; treating autoimmune diseases, AIDS, inflammatory diseases, cardiovascular disorder of ischemic processes, allograft rejection, cerebral strokes, traumas, burns, Alzheimer's disease, Parkinson's disease |
| 03/27/2008 | US20080076716 Anti-Microbial Defensin-Related Peptides and Methods of Use |
| 03/27/2008 | US20080076709 Isolated polypeptide, encoded by nucleic acid sequence, a vector from Staphylococcus; use for activators or inhibitors in therapy, antigen for vaccination, antibodies; antibacterial agent treating Staphylococcus infections; biodrugs |
| 03/27/2008 | US20080076667 Substituted fluoroalkoxyphenylsulfonylureas |
| 03/27/2008 | US20080076175 Generating transgenic lymphoid cell comprising sequences coding immunoglobulin epitope for use in tissue targeted therapies |
| 03/27/2008 | US20080076146 Harvesting, separating, culturing and exposing tissue to antiproliferative agents, monitoring variation in tissue propagation; immunotherapeutics; wound healing agents |
| 03/27/2008 | US20080075795 Method and composition for preventing and treating avian influenza in poultry |
| 03/27/2008 | US20080075765 Methods and materials for reducing risk of cold and/or flu |
| 03/27/2008 | US20080075762 Compositions for delivery of drug combinations |
| 03/27/2008 | US20080075745 Topical pharmaceutical compositions containing ciclopirox or a pharmaceutically acceptable salt thereof |
| 03/27/2008 | US20080075743 antigenic material from one or more inactivated dermatophyte strains; stable immunogenic properties, easy preparation, high content of microconidia and lack of side reactions in animals; treating skin disorders |
| 03/27/2008 | US20080075742 synergistic biomedical activity as immunostimulants; biodrugs for prevention and/or treatment of cancer, treatment of allergic conditions, malignancies, chronic infections, autoimmune phenomena and age-related imbalances; adverse side effects of irradiation |
| 03/27/2008 | US20080075741 Recombinant P. falciparum merozoite protein-1 42 vaccine |
| 03/27/2008 | US20080075740 Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor |
| 03/27/2008 | US20080075739 Attenuated Salmonella SP12 Mutants as Antigen Carriers |
| 03/27/2008 | US20080075738 synthetic polypeptide biodrugs for treating viral disease; envelope protein, antigens, consisting of amino acid sequances from virus, more potent, protecting from T helper and B cell immunity |
| 03/27/2008 | US20080075737 inducing an immune response to an HIV antigen; genetic engineered polypeptide; inserted into cell; improves or restores the blood clotting time, blood disorders; gene therapy |
| 03/27/2008 | US20080075736 Materials and methods for respiratory disease control in canines |
| 03/27/2008 | US20080075729 ras-mediated; administering immunosuppressive for immune constituents that may interfere with the systemic delivery of the reovirus; antiproliferative; in the neoplastic cells phosphorylation of PKR is prevented by inactivation or deletion of PKR; antitumor agents |
| 03/27/2008 | US20080075717 Antigen Imitating Extracellular Areas of Membrane Proteins of Type III Produced from Intracellular Pathogenic Micro-Organisms, Derived Conformational Antibodies and the Use Thereof |
| 03/27/2008 | US20080075712 replacement for ligand of a heteromolecule-comprising a dimer, cytokine or interferon receptors; antibodies recognizing both an enzyme and a substrate, such as proteolytic enzymes and blood coagulation/fibrinolysis associated factors; prevention of bleeding and/or blood disorders |
| 03/27/2008 | US20080075708 compounds having an anchoring domain that anchors the compound to the surface of target cell, and a therapeutic domain that can act extracellularly to prevent infection of the target cell by a pathogen, such as viruses; neuraminidase |
| 03/27/2008 | US20080075695 Combination therapy method for treating hepatitis c virus infection and pharmaceutical compositions for use therein |
| 03/27/2008 | US20080075673 selected from propane, n-butane, isobutane or 2-methylbutane, used in refrigerants, refrigerators, blowing agents and aerosol propellants; pollution control |
| 03/27/2008 | DE102007024383A1 Ddeodorant or antiperspirant composition comprises an antibody that is directed against a defined microorganism and is isolated from egg yolk |
| 03/27/2008 | DE102007024381A1 Topical composition for treating acne, pimples, bad skin or seborrhea comprises an antibody that is directed against a defined microorganism and is isolated from egg yolk |
| 03/27/2008 | CA2663776A1 Rifaximin in an amorphous form |
| 03/27/2008 | CA2663057A1 N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase |
| 03/27/2008 | CA2662835A1 Octahydropyrrolo [3, 4-c] pyrrole derivatives and their use as antiviral agents |
| 03/27/2008 | CA2662773A1 N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase |
| 03/26/2008 | EP1903113A1 Multifunctional protease inhibitors and their use in treatment of disease |
| 03/26/2008 | EP1903068A1 Biodegradable poly(beta-amino esters) and uses thereof |
| 03/26/2008 | EP1903055A2 Recombinant haemophilus influenzae adhesin proteins |
| 03/26/2008 | EP1903054A2 Pharmaceutical compound containing a stabilised mRNA which is optimised for translation in its coded areas |
| 03/26/2008 | EP1903041A2 Polymorphic and other crystalline forms of cis-FTC |
| 03/26/2008 | EP1903035A2 High purity butoconazole nitrate with specified particle size and a process for preparation of thereof |
| 03/26/2008 | EP1902726A2 Compositions comprising neisseria meningitidis antigens from serogroups b and c |
| 03/26/2008 | EP1902724A2 Antimicrobial compositions |
| 03/26/2008 | EP1902721A1 Ernährungs- und medizinische Zusammensetzungen enthaltend Vaccinium macrocarpon |
| 03/26/2008 | EP1902719A2 Agent exhibiting bactericidal action with respect to vegetative and spore cells bacillus anthrasis, anthrax preventing and treating method |
| 03/26/2008 | EP1902057A1 Macrocyclic heterocyclic aspartyl protease inhibitors |
| 03/26/2008 | EP1902050A1 Oxazolidinone derivatives and use thereof as antibiotics |
| 03/26/2008 | EP1902037A1 2,4-diamino-pyrimidines used as aurora inhibitors |
| 03/26/2008 | EP1902030A1 Substituted quinolones ii |
| 03/26/2008 | EP1902017A1 Antiviral compounds and methods |
| 03/26/2008 | EP1901777A2 Low-toxicity, long-circulating chimeras of human interferon-alpha analogs and interferon tau |
| 03/26/2008 | EP1901768A1 Methods of modulating il-23 activity; related reagents |
| 03/26/2008 | EP1901752A2 Compositions and methods for viral inhibition |
| 03/26/2008 | EP1901743A1 Quinoline derivatives as antibacterial agents |
| 03/26/2008 | EP1901723A2 Antimicrobial materials |
| 03/26/2008 | EP1585497B1 Mastitis treatment with a combination of prednisolon and cephalosporin |
| 03/26/2008 | EP1527089B1 Mixture of peptides from c and ns3 proteins of the hepatitis c virus and applications thereof |
| 03/26/2008 | EP1509218A4 Peptide deformylase inhibitors |
| 03/26/2008 | EP1490037B1 Taste masked veterinary solid compositions |
| 03/26/2008 | EP1448784B1 Antibiotics ge 81112 factors a, b, b1, pharmaceutically acceptable salts and compositions, and use thereof |
| 03/26/2008 | EP1339373B1 Use of moulding compounds for producing treatment devices |
| 03/26/2008 | EP1248847B1 Irak-4: compositions and methods of use |
| 03/26/2008 | EP0879060B1 Vaccines against varicella zoster virus gene 63 product |
| 03/26/2008 | EP0871482B1 Recombinant vesiculoviruses and their uses |
| 03/26/2008 | EP0672147B1 Protein conferring an inducible resistance to glycopeptides, particularly in gram-positive bacteria |
| 03/26/2008 | CN101151254A Diketo acids with nucleobase scaffolds: anti-HIV replication inhibitors targeted at HIV integrase |
| 03/26/2008 | CN101151046A Anti-viral agent |
| 03/26/2008 | CN101151032A Pharmaceutical composition and method using antifungal agent in combination |
| 03/26/2008 | CN101148680A Method for leading plasmid carrier containing gene cure segment in cell by nano particles |
| 03/26/2008 | CN101148470A Antibacterial/neutral endotoxin allosteric peptide molecule modified by polyglycol, synthesizing method and medical use thereof |
| 03/26/2008 | CN101148466A RNA disturbance target point for inhibiting MDV proliferating and application thereof |
| 03/26/2008 | CN101148463A Azithromycin derivative and application thereof |
| 03/26/2008 | CN101148462A Azithromycin derivative and application thereof |
| 03/26/2008 | CN101148461A Azithromycin derivative and application thereof |
| 03/26/2008 | CN101148460A Azithromycin derivative and application thereof |
| 03/26/2008 | CN101148445A Method for preparing o-dihydroxyflavone-selenium complexes and medical use |
| 03/26/2008 | CN101148441A Andrographolidi natrii bisulfis and preparation method thereof |
| 03/26/2008 | CN101148418A Alpine yarrow herb ketoacid derivatives and applications thereof |
| 03/26/2008 | CN101147792A Method for preparing capsule for treating hepatitis B, clearing heat and antitoxic |
| 03/26/2008 | CN101147788A Medicine for treating cold and upper respiratory tract infection and its lung inflammation |
| 03/26/2008 | CN101147783A Medicinal liquor for preventing and treating venereal disease and man's medicine cover and woman's tissue containing the medicinal liquor |
| 03/26/2008 | CN101147775A Medicine preparation for treating hepatopathy |
| 03/26/2008 | CN101147768A Medicine for treating filtration virus infection and its processing method |
| 03/26/2008 | CN101147757A Traditional Chinese medicine for treating chronic hepatitis B and its preparation process |
| 03/26/2008 | CN101147756A Medicinal composition containing total alooerine and licorice total flavone |
| 03/26/2008 | CN101147755A Medicinal preparation for treating hepatitis B |
| 03/26/2008 | CN101147752A Biologic active element and its preparation technology |
| 03/26/2008 | CN101147751A Method for extracting biologically active component from momordica grosvenori plant |
| 03/26/2008 | CN101147742A Medicinal composition containing licorice total flavone and alooerine |
| 03/26/2008 | CN101147738A Dihydroartemisinin and metronidazole combination |
| 03/26/2008 | CN101147734A Compositions and method for treating infection |
| 03/26/2008 | CN101147728A 6-methocy bideoxy bideoxy guanosine long circulating liposome preparation and preparing method |
| 03/26/2008 | CN101147727A Curcumol submicron emulsion and preparation method and preparation thereof |